During the past decade, CoxHealth South Hospital conducted 222 clinical trials. In the 10-year time frame, 222 clinical trials started and 166 clinical trials were completed, i.e. on average, 74.8% percent of trials that started reached the finish line to date. In the past 5 years, 89 clinical trials started and 103 clinical trials were completed. i.e. 115.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CoxHealth South Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 167 trials, followed by "SWOG Cancer Research Network" with 44 trials sponsored, "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 25 trials sponsored and "Gynecologic Oncology Group" with 25 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CoxHealth South Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 168 trials as a collaborator, "NRG Oncology" with 54 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "CoxHealth South Hospital" are "Recurrent Ovarian Carcinoma" (20 trials), "Recurrent Fallopian Tube Carcinoma" (15 trials), "Recurrent Primary Peritoneal Carcinoma" (15 trials), "Invasive Breast Carcinoma" (12 trials) and "Cervical Adenocarcinoma" (11 trials). Many other conditions were trialed in "CoxHealth South Hospital" in a lesser frequency.

Most popular intervention types in "CoxHealth South Hospital" are "Drug" (275 trials), "Other" (225 trials), "Biological" (128 trials), "Procedure" (86 trials) and "Radiation" (54 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (117 trials), "Quality-of-Life Assessment" (82 trials), "Questionnaire Administration" (51 trials), "Paclitaxel" (50 trials) and "Carboplatin" (44 trials). Other intervention names were less common.

The vast majority of trials in "CoxHealth South Hospital" are 262 trials for "All" genders, 92 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "CoxHealth South Hospital". undefined are not yet recruiting, 86 are recruiting, 142 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 100 completed trials in CoxHealth South Hospital, 8 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in CoxHealth South Hospital, 9 "Phase 1" clinical trials were conducted, 175 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 21 trials that are defined as “Not Applicable".

CoxHealth South Hospital has several departments that took part in Clinical trials: "Hulston Cancer Center at Cox Medical Center South" - 134 trials, "Cox Cancer Center Branson" - 160 trials, "CoxHealth Cancer Center" - 29 trials